Sun, 20 Apr 2025 07:14:33 GMT (1745133273754) Story Infinite Scroll - News3 v1.0.0 (common) 69c80f1ee7655405ad92e63c4577173aeef8f823 ...

The data showed smoking and concomitant selective CCB use were more common among patients with angioedema (odds ratio [OR] 4.3, 95% CI: 2.1–8.9; P=0.000022) vs. cough (OR 3.7, 95% CI: 2.0–7.0 ...

Meta-analysis of ACE inhibitor–induced angioedema identifies novel risk locus. Journal of Allergy and Clinical Immunology , 2024; DOI: 10.1016/j.jaci.2023.11.921 Cite This Page : ...

Patients with ACE-inhibitor-induced angioedema recovered nearly three times faster with the administration of the bradykinin inhibitor icatibant than those given a standard glucocorticoid ...

Icatibant, a bradykinin B2 receptor antagonist, was no better than placebo in treating moderately severe angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema of the upper airway ...

In a triple blind, placebo-controlled phase-2 trial, researchers studied the drug Ecallantide for ACE inhibitor induced angioedema that failed to respond to the conventional therapy of ...

A multicenter clinical trial (NCT01919801) investigating icatibant for patients with ACE inhibitor-induced angioedema is expected to be completed next year, according to the drug manufacturer.

Angioedema is a rare but potentially life-threatening adverse reaction to ACE inhibitors. In a joint analysis of eight European study collectives, researchers from the University Hospital Bonn ...

The authors note that most angioedema induced by inhibition of DPP IV occurs during concomitant angiotensin-converting enzyme inhibitor treatment and is likely to be mediated by bradykinin type 2 ...

Moellman says there's currently no treatment for ACE inhibitor induced (ACEI) angioedema, as the physiology of the condition is different—caused by the levels of the blood vessel-dilating ...